Correction: L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2)

Imma Forzano; Roberta Avvisato; Fahimeh Varzideh; Stanislovas S. Jankauskas; Angelo Cioppa; Pasquale Mone; Luigi Salemme; Urna Kansakar; Tullio Tesorio; Valentina Trimarco; Gaetano Santulli

doi:10.1186/s12933-023-01852-1

Correction: L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2)

Imma Forzano, Roberta Avvisato, Fahimeh Varzideh, Stanislovas S. Jankauskas, Angelo Cioppa, Pasquale Mone, Luigi Salemme, Urna Kansakar, Tullio Tesorio, Valentina Trimarco, Gaetano Santulli

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Following publication of the original article [1], the conflict of interest statement has been updated with this correction. Conflict of Interest Gaetano Santulli declares that he is Associate Editor of Cardiovascular Diabetology and that the article was assigned to another Editor to assume responsibility for overseeing peer review. This submissions was subject to the exact same review process as any other manuscript submitted to the journal.

Original language	English (US)
Article number	117
Journal	Cardiovascular Diabetology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1186/s12933-023-01852-1
State	Published - Dec 2023

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12933-023-01852-1

Cite this

Forzano, I., Avvisato, R., Varzideh, F., Jankauskas, S. S., Cioppa, A., Mone, P., Salemme, L., Kansakar, U., Tesorio, T., Trimarco, V., & Santulli, G. (2023). Correction: L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2). Cardiovascular Diabetology, 22(1), Article 117. https://doi.org/10.1186/s12933-023-01852-1

Forzano, I, Avvisato, R, Varzideh, F, Jankauskas, SS, Cioppa, A, Mone, P, Salemme, L, Kansakar, U, Tesorio, T, Trimarco, V & Santulli, G 2023, 'Correction: L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2)', Cardiovascular Diabetology, vol. 22, no. 1, 117. https://doi.org/10.1186/s12933-023-01852-1

@article{b9498a26d0594a5d953a3c8c25e2e367,

title = "Correction: L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2)",

abstract = "Following publication of the original article [1], the conflict of interest statement has been updated with this correction. Conflict of Interest Gaetano Santulli declares that he is Associate Editor of Cardiovascular Diabetology and that the article was assigned to another Editor to assume responsibility for overseeing peer review. This submissions was subject to the exact same review process as any other manuscript submitted to the journal.",

author = "Imma Forzano and Roberta Avvisato and Fahimeh Varzideh and Jankauskas, {Stanislovas S.} and Angelo Cioppa and Pasquale Mone and Luigi Salemme and Urna Kansakar and Tullio Tesorio and Valentina Trimarco and Gaetano Santulli",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2023",

month = dec,

doi = "10.1186/s12933-023-01852-1",

language = "English (US)",

volume = "22",

journal = "Cardiovascular Diabetology",

issn = "1475-2840",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2)

AU - Forzano, Imma

AU - Avvisato, Roberta

AU - Varzideh, Fahimeh

AU - Jankauskas, Stanislovas S.

AU - Cioppa, Angelo

AU - Mone, Pasquale

AU - Salemme, Luigi

AU - Kansakar, Urna

AU - Tesorio, Tullio

AU - Trimarco, Valentina

AU - Santulli, Gaetano

PY - 2023/12

Y1 - 2023/12

N2 - Following publication of the original article [1], the conflict of interest statement has been updated with this correction. Conflict of Interest Gaetano Santulli declares that he is Associate Editor of Cardiovascular Diabetology and that the article was assigned to another Editor to assume responsibility for overseeing peer review. This submissions was subject to the exact same review process as any other manuscript submitted to the journal.

AB - Following publication of the original article [1], the conflict of interest statement has been updated with this correction. Conflict of Interest Gaetano Santulli declares that he is Associate Editor of Cardiovascular Diabetology and that the article was assigned to another Editor to assume responsibility for overseeing peer review. This submissions was subject to the exact same review process as any other manuscript submitted to the journal.

UR - http://www.scopus.com/inward/record.url?scp=85159781208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159781208&partnerID=8YFLogxK

U2 - 10.1186/s12933-023-01852-1

DO - 10.1186/s12933-023-01852-1

M3 - Comment/debate

C2 - 37208744

AN - SCOPUS:85159781208

SN - 1475-2840

VL - 22

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

IS - 1

M1 - 117

ER -

Correction: L-Arginine in diabetes: clinical and preclinical evidence (Cardiovascular Diabetology, (2023), 22, 1, (89), 10.1186/s12933-023-01827-2)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this